D3 Bio, a China-based clinical-stage biotech company backed by Temasek, raised a USD62m Series A+ led by Medicxi, with follow-on from Matrix Partners China and WuXi AppTec. Read More
CVC Capital Partners fully exited its 5% stake in Vietnam-based commercial lender Asia Commercial Bank for USD220m. Read More
Trustar Capital, the private equity affiliate of CITIC Capital, acquired Guilong Pharmaceutical, a China-based OTC medicine manufacturer for sore throats. … Read More
Kotak Alternate Asset Managers and Abu Dhabi Investment Authority agreed to invest INR20b (~USD240m) in India-based real estate developer Prestige Group. Read More
GPCA markets are searching for a new normal. After an unprecedented wave of activity during COVID-19, venture capital (VC) deal value and count fell for the second straight year in 2023. As startup valuations and deal activity stabilize, experienced fund managers across global markets remain well capitalized and positioned to… Read More
KKR agreed to invest USD400m in Pinnacle Towers, a Philippines-based independent telecom tower operator. KKR first invested in the company in 2020. Read More
MPower Partners led a USD10.2m Series B1 for Rukita, an Indonesia-based move-in-ready apartment rental platform, with participation from Openspace Ventures, Golden Gate Ventures, BNI Ventures, Jeremy Lin and others. Read More
Triple P Capital agreed to raise USD200m for its second fund focusing on the climate sector, specifically climate adaptation and resilience in Southeast Asia. … Read More
Actis exited its 75% stake in SIS Group, an Indonesia-based private school chain operating in Indonesia, India, South Korea and Myanmar, via a sale to Adivira Capital. Read More
ADB Ventures agreed to raise USD200m for its climate fund, focusing on Series A and pre-Series A startups in Asia. Read More
(default archive template)